Opportunity Information: Apply for CDC RFA PS13 1304
Apply for CDC RFA PS13 1304
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Tuberculosis Regional Training and Medical Consultation Centers" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.947 Tuberculosis Demonstration, Research, Public and Professional Education.
- This funding opportunity was created on Jul 6, 2012 and posted on Jul 5, 2012.
- Applicants must submit their applications by Aug 20, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $27,978,880.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,398,944.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below Public, non profit organizations Private, non profit organizations For profit organizations Universities Colleges Hospitals Community based organizations Federally recognized Indian tribal governments Indian tribal organizations U.S. State and local governments or their bona fide agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of U.S. States (in consultation with States)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC) grant opportunity titled "Tuberculosis Regional Training and Medical Consultation Centers" (Funding Opportunity Number CDC RFA PS13-1304) is a discretionary cooperative agreement designed to strengthen tuberculosis (TB) prevention and control capacity across the United States by funding a small network of Regional Training and Medical Consultation Centers (RTMCCs). These centers are intended to function as regional "centers of excellence" that support TB programs, clinicians, and public health partners by improving the workforce and expanding access to expert clinical guidance. The program anticipates funding up to five awards, with centers distributed geographically so multiple regions of the country are covered rather than concentrating resources in one area.
The opportunity is built around two core program goals. First, RTMCCs are expected to increase human resource development (HRD) for TB prevention and control through education and training. In practice, this means building and delivering training opportunities for the professionals involved in TB work, such as public health staff, nurses, physicians, outreach workers, laboratorians, and others who support TB case detection, treatment, contact investigations, and prevention of transmission. Second, the centers must increase the capacity for appropriate medical evaluation and management of people with TB disease and TB infection by providing medical consultation. That consultation function is aimed at strengthening clinical decision-making and supporting providers and TB programs when they face challenging cases, questions about diagnosis or treatment, or management issues that require specialized TB expertise.
Funding provided for the centers is primarily intended to support domestic activities, meaning U.S.-based education, training, and medical consultation services. The announcement also notes that if additional CDC funds later become available for international projects, the CDC may request a letter of intent from funded entities to participate in those international efforts. In other words, the core award focuses on U.S. TB capacity, with a potential optional expansion if separate funding is offered later.
From a funding and administrative standpoint, the total estimated funding listed for the announcement is $27,978,880, with an award ceiling of $1,398,944 and no required cost sharing or matching. The cooperative agreement mechanism signals that CDC expects to have substantial involvement in the work, typically through collaboration, technical direction, coordination expectations, performance monitoring, and alignment with national TB priorities, rather than simply issuing a grant with minimal federal interaction.
Eligibility is broad and includes many types of entities that could credibly serve as regional centers, including public and private nonprofit organizations, for-profit organizations, universities, colleges, hospitals, community-based organizations, federally recognized tribal governments and tribal organizations, and U.S. state and local governments or their bona fide agents. The eligible geography includes U.S. states and several U.S. territories and freely associated states listed in the announcement, such as the District of Columbia, Puerto Rico, the U.S. Virgin Islands, Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. Political subdivisions of U.S. states may also apply in consultation with their states. This wide eligibility range reflects the fact that TB expertise and training infrastructure may reside in academic medical centers, public health agencies, hospital systems, and specialized nonprofit or community organizations.
Key timeline information in the source data indicates the opportunity was posted on July 5, 2012, created July 6, 2012, with an original closing date of August 7, 2012 that was extended to a current closing date of August 20, 2012. The archive date is listed as September 19, 2012. The CFDA number associated with this program is 93.947, "Tuberculosis Demonstration, Research, Public and Professional Education," placing the opportunity within CDCs TB-related training and public/professional education funding portfolio.
For applicants or interested parties who have trouble accessing the full announcement, the CDC Procurement and Grants Office is listed as the point of contact, with phone number 770-488-2700 and email pgotim@cdc.gov. Overall, the grant is essentially a national capacity-building effort structured around a small number of regionally assigned centers that can train the TB workforce and provide expert medical consultation to improve the prevention, diagnosis, and management of TB infection and disease in the United States.
Frequently Asked Questions (FAQs)
1. What is the name of this CDC funding opportunity?
The opportunity is titled "Tuberculosis Regional Training and Medical Consultation Centers."
2. What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA PS13-1304.
3. What type of funding mechanism is this?
This is a discretionary cooperative agreement.
4. What does a cooperative agreement imply for applicants and awardees?
The cooperative agreement mechanism indicates CDC expects substantial involvement in the funded work. Based on the announcement description, this typically includes collaboration, technical direction, coordination expectations, performance monitoring, and alignment with national tuberculosis priorities rather than minimal federal interaction.
5. What is the overall purpose of this program?
The program is intended to strengthen tuberculosis (TB) prevention and control capacity across the United States by funding a small network of Regional Training and Medical Consultation Centers (RTMCCs) that function as regional centers of excellence.
6. How many awards does CDC anticipate making?
The program anticipates funding up to five awards.
7. Will the funded centers be concentrated in one area of the country?
No. The intent is to distribute the centers geographically so multiple regions of the country are covered rather than concentrating resources in one area.
8. What are the two core program goals for RTMCCs?
The two core goals are: (1) increasing human resource development (HRD) for TB prevention and control through education and training, and (2) increasing capacity for appropriate medical evaluation and management of people with TB disease and TB infection by providing medical consultation.
9. What does "human resource development (HRD)" mean in this program?
In this context, HRD means building and delivering education and training opportunities to strengthen the TB workforce involved in TB case detection, treatment, contact investigations, and prevention of transmission.
10. Who is the intended audience for the training supported by RTMCCs?
The training is intended for professionals involved in TB work, including public health staff, nurses, physicians, outreach workers, laboratorians, and others who support TB prevention and control activities.
11. What is meant by the "medical consultation" function?
Medical consultation is intended to expand access to expert clinical guidance by supporting providers and TB programs with challenging cases or questions related to diagnosis, treatment, and management that require specialized TB expertise.
12. Is the funding intended for domestic or international work?
Funding for the centers is primarily intended to support domestic (U.S.-based) education, training, and medical consultation services.
13. Does the announcement mention any possible international work?
Yes. The announcement notes that if additional CDC funds later become available for international projects, CDC may request a letter of intent from funded entities to participate in those international efforts. This would be separate from the core domestic focus and dependent on additional funds becoming available.
14. What is the total estimated funding amount for the announcement?
The total estimated funding listed is $27,978,880.
15. What is the award ceiling?
The award ceiling is $1,398,944.
16. Is cost sharing or matching required?
No. The announcement specifies that there is no required cost sharing or matching.
17. What types of organizations are eligible to apply?
Eligibility is broad and includes public and private nonprofit organizations, for-profit organizations, universities, colleges, hospitals, community-based organizations, federally recognized tribal governments and tribal organizations, and U.S. state and local governments or their bona fide agents.
18. Are tribal entities eligible?
Yes. Federally recognized tribal governments and tribal organizations are included in the eligible applicant types.
19. Are for-profit organizations eligible to apply?
Yes. For-profit organizations are included in the eligible applicant types.
20. What geographic areas are eligible under this opportunity?
The eligible geography includes U.S. states and several U.S. territories and freely associated states listed in the announcement: the District of Columbia, Puerto Rico, the U.S. Virgin Islands, Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
21. Can political subdivisions of U.S. states apply?
Yes. Political subdivisions of U.S. states may apply in consultation with their states.
22. What is the CFDA number for this program?
The CFDA number is 93.947, "Tuberculosis Demonstration, Research, Public and Professional Education."
23. When was the opportunity posted?
The opportunity was posted on July 5, 2012.
24. What is the created date listed for the opportunity?
The created date is July 6, 2012.
25. What was the original closing date and was it extended?
The original closing date was August 7, 2012, and it was extended.
26. What is the current closing date?
The current closing date listed is August 20, 2012.
27. What is the archive date for the opportunity?
The archive date is September 19, 2012.
28. Who can be contacted for help accessing the full announcement?
The CDC Procurement and Grants Office is listed as the point of contact for assistance accessing the full announcement.
29. What are the contact details for the CDC Procurement and Grants Office?
Phone: 770-488-2700
Email: pgotim@cdc.gov
30. In practical terms, what is CDC trying to build through this network of centers?
A small, regionally distributed network of centers of excellence that improves the TB workforce through training and expands access to expert clinical guidance through medical consultation, with the overall aim of improving TB prevention, diagnosis, and management across the United States.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24)
Previous opportunity: To promote and engage in the protection and preservation of the El Camino Real de Tierra Adentro National Historic Trail
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 1304
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 1304) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition National NeuroAIDS Tissue Consortium (NNTC) Clinical Sites (U24) Apply for RFA MH 13 070 Funding Number: RFA MH 13 070 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National NeuroAIDS Tissue Consortium (NNTC) Data Coordinating Center (DCC) (U24) Apply for RFA MH 13 071 Funding Number: RFA MH 13 071 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01) Apply for RFA AR 13 004 Funding Number: RFA AR 13 004 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIMHD Transdisciplinary Collaborative Centers for Health Disparities Research (U54) Apply for RFA MD 12 007 Funding Number: RFA MD 12 007 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA TR 12 006 Funding Number: RFA TR 12 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Program Apply for HRSA 12 156 Funding Number: HRSA 12 156 Agency: Health Resources and Services Administration Category: Health Funding Amount: $3,000,000 |
| Identification and Analysis of Causal Variants Follow Up on Genome Wide Association Studies for Arthritis and Musculoskeletal and Skin Diseases (R21) Apply for PAR 12 230 Funding Number: PAR 12 230 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Identification and Analysis of Causal Variants Follow Up on Genome Wide Association Studies for Arthritis and Musculoskeletal and Skin Diseases (R01) Apply for PAR 12 236 Funding Number: PAR 12 236 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) Apply for PA 12 234 Funding Number: PA 12 234 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) Apply for PA 12 235 Funding Number: PA 12 235 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Specialized Neuroscience Research Program (SNRP) (U54) Apply for RFA NS 13 004 Funding Number: RFA NS 13 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stem Cells and Alcohol induced Tissue Injuries (R01) Apply for PA 12 233 Funding Number: PA 12 233 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stem Cells and Alcohol induced Tissue Injuries (R21) Apply for PA 12 232 Funding Number: PA 12 232 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Tobacco Centers of Regulatory Science for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P50) Apply for RFA DA 13 003 Funding Number: RFA DA 13 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Renewal of Centers of Biomedical Research Excellence (COBRE)P20 Apply for PAR 12 224 Funding Number: PAR 12 224 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinically Relevant Genetic Variants Resource A Unified Approach for Identifying Genetic Variants for Clinical Use (U01) Apply for RFA HG 12 016 Funding Number: RFA HG 12 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Fatigability, Activity Limitations, and Bioenergetics in Aging (R21) Apply for PA 12 225 Funding Number: PA 12 225 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Fatigability, Activity Limitations, and Bioenergetics in Aging (R03) Apply for PA 12 226 Funding Number: PA 12 226 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Fatigability, Activity Limitations, and Bioenergetics in Aging (R01) Apply for PA 12 227 Funding Number: PA 12 227 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Organizations for Chronic Disease Prevention and Health Promotion CDC RFA DP10 1008 Apply for CDC RFA DP10 10080301SUPP12 Funding Number: CDC RFA DP10 10080301SUPP12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 1304", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.